Optimization studies on floating multiparticulate gastroretentive drug delivery system of famotidine

Drug Development and Industrial Pharmacy

Volumn 34, Issue 11, 2008, Pages 1201-1208

  Gupta, Reshu ^a   Pathak, Kamla ^a  

^a NH 2   (India)

Author keywords

Emulsion solvent diffusion method; Famotidine; Fractionation; Mesh designed apparatus; Microballoons

Indexed keywords

EUDRAGIT; FAMOTIDINE; POLYMER;

ARTICLE; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG RETENTION; EMULSION; ENCAPSULATION; PARTICLE SIZE; STOMACH;

CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FAMOTIDINE; GASTROINTESTINAL AGENTS; MICROSPHERES; PARTICLE SIZE;

EID: 54349104720     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802005016     Document Type: Article

References (19)

1. Allen, L. V., Popovich, N. G., & Ansel, H. C. (2004). Ansel's pharmaceutical dosage forms and drug delivery systems. Philadelphia: Lippincott Williams and Wilkins.
2. Arora, S., Ali, J., Ahuja, A., Khar, R. K., & Baboota, S. (2005). Floating drug delivery systems: A review. AAPS Pharm. Sci. Tech., 6(03), 372-390.
3. Bardonnet, P. L., Faivre, V., Pugh, W. J., Piffaretti J. C., & Falson, F. (2006). Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. J. Control. Release, 111, 1-18.
4. Bolton, S. (1997). Pharmaceutical statistics: Practical and clinical applications. New York: Marcel Dekker.
5. Burns, S. J., Attwood, D., & Barnwell, S. G. (1994). Assessment of a dissolution vessel designed for use with floating and erodible dosage forms. Int. J. Pharm., 160, 213-218.
6. Desai, S., & Bolton, S. (1993). A floating controlled release drug delivery system: In vitro-in vivo evaluation. Pharm. Res., 10, 1321-1325.
7. Deshpande, A. A., Rhodes, C. T., Shah, N. H., & Malick, A. W. (1996). Controlled release drug delivery systems for prolonged gastric residence; an overview. Drug Dev. Ind. Pharm., 22, 531-539.
8. Jain, K. N. (2004). Progress in controlled and novel drug delivery systems. New Delhi, India: CBS publishers and distributors.
9. Jain, K. S., Acanthi, A. M., Jain, K. N., & Agrawal, P. G. (2005). Calcium silicate based microspheres of repaglinide for gastro retentive floating drug delivery: Preparation and in vitro characterization. J. Control. Release, 107(2), 300-309.
10. Kawashima, Y., Niwa, T., Takeuchi, H., Hino, T., & Itoh, Y. (1992). Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J. Pharm. Sci., 81, 135-140.
11. Kostewicz, E. S., Wunderlich, M., Brauns, U., Becker, R., Bock, T., & Dressman, J. B. (2004). Prediction of precipitation of poorly soluble weak bases upon entry in the small intestine, J.Pharm. Pharmacol., 56, 43-51.
12. Patil, J. M., Hirlekar, R. S., Gide, P. S., & Kadam, V. J. (2006). Trends in floating drug delivery system. J. Sci. Ind. Res., 65, 11-21.
13. Read, N. W., & Sugden, K. (1987). Gastrointestinal dynamics and pharmacology for the optimum design of controlled release oral dosage forms. CRC Crit. Rev. Ther. Drug. Carrier Syst., 4(3), 221-263.
14. Rowe, R. C., Sheskey, P. J., & Oven, S. C. (2006). Handbook of pharmaceutical excipients. London: Pharmaceutical Press.
15. Sriamornsak, P., Thirawong, N., & Puttipipatkhachorn, S. (2004). Morphology and bouyancy of oil-entrapped calcium pectinate gel beads. AAPS J. Pharm. Sci. Tech., No. 3, E24.
16. Sweetman, S. C. (2002). Martindale: The complete drug reference. London: Pharmaceutical Press.
17. Vyas, S. P., & Khar, R. K. (2002). Controlled drug delivery: Concepts and advances. New Delhi, India: Vallabh Prakashan.
18. Wells, J. (2002). Pharmaceutical Preformulation: The physicochemical properties of drug substances. M. E. Aulton (Ed.), Pharmaceutics: The science of dosage form design (pp. 113-151). London: Churchill Livingstone.
19. Whitehead, L., Fell, J. T., Collett, J. H., Sharma, H. L., & Smith, A. M. (1998). An in vivo study demonstrating prolonged gastric retention. J. Control. Release, 55, 3-12.